#United States #New York #Class Action #Pomerantz Law #Rocket Lab

Pomerantz Law Firm Issues Alert to Rocket Lab Investors

On April 28, 2025, the Pomerantz Law Firm announced the initiation of a class action lawsuit against Rocket Lab USA, Inc. (NASDAQ: RKLB), alerting investors of significant developments regarding their rights. The lawsuit centers on allegations suggesting that Rocket Lab and certain officials may have misled investors by engaging in the unlawful manipulation of business practices. Investors who have faced losses and purchased Rocket Lab shares during the class period are encouraged to take action before the deadlines set by the court.

Important Details for Investors

Investors who believe they have been affected can contact Danielle Peyton of Pomerantz LLP via email at [email protected] or by phone at 646-581-9980, and toll-free at 888-4-POMLAW, Ext. 7980. It is advisable for interested parties to provide a mailing address, telephone number, and details regarding their purchases of Rocket Lab shares. The deadline to be appointed as a Lead Plaintiff is April 28, 2025.

Allegations from the Bleeker Street Research Report

Recent allegations were reported on February 25, 2025, by Bleeker Street Research, claiming that Rocket Lab misrepresented the timeline and feasibility of its Neutron rocket's launch scheduled for mid-2025. The report pointed out that Rocket Lab had delayed its planned barge landing tests originally set between September 2024 and March 2025, pushing them back to as late as March 2026.

Further, it was revealed that the necessary preparations for the launch pad were significantly behind schedule, with critical issues, such as potable water supply, not expected to be resolved until January 2026. Additionally, it was disclosed that Rocket Lab’s only existing contract for the Neutron project was with a startup called E-Space, which was labeled as a “risk item” due to its unreliability. Contrary to earlier statements by Rocket Lab, the contract was not a full-price agreement.

Impact on Rocket Lab's Stock Price

In the wake of these claims, investors reacted swiftly, leading to a decline in Rocket Lab's stock price by $2.21 per share, amounting to a decrease of approximately 9.83%, and closing at $20.28 on the same day the report was published. This decline has raised further scrutiny and concern among investors regarding the company's transparency and operational integrity.

About Pomerantz Law Firm

Pomerantz LLP is widely recognized for its expertise in corporate, securities, and antitrust class litigation. Established over 85 years ago by Abraham L. Pomerantz, the firm has successfully represented victims of securities fraud and corporate misconduct. Pomerantz has secured numerous multimillion-dollar damages awards for its clients, and it continues the legacy set forth by its founder in pursuing justice for affected investors. More information about the firm can be found on their official website, www.pomerantzlaw.com.

Conclusion

Investors in Rocket Lab should remain vigilant and be proactive, particularly if they have incurred losses during the pertinent class period. The ongoing developments highlight the importance of being informed and taking necessary actions in light of potential securities fraud. Those who wish to be included in the lawsuit need to act before the deadline to ensure that their rights are duly protected.